FRED HUTCHINSON CANCER CENTER
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Atypical Chronic Myeloid Leukemia, BCR-ABL NegativeMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiableNoncontiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Adult Immunoblastic Large Cell LymphomaRecurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Mantle Cell LymphomaRecurrent Mycosis Fungoides/Sezary Syndrome
- Interventions
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2017-05-23
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 49
- Registration Number
- NCT00795769
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma
- Conditions
- Interventions
- Procedure: Autologous Hematopoietic Stem Cell TransplantationDrug: BortezomibDrug: CyclosporineDrug: Fludarabine PhosphateOther: Laboratory Biomarker AnalysisDrug: MelphalanDrug: Mycophenolate MofetilProcedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell TransplantationProcedure: Peripheral Blood Stem Cell TransplantationProcedure: Syngeneic Bone Marrow TransplantationRadiation: Total-Body Irradiation
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 32
- Registration Number
- NCT00793572
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer
- Conditions
- Acute Lymphoblastic LeukemiaDiffuse Large B-Cell LymphomaAcute Myeloid LeukemiaRefractory Chronic Lymphocytic LeukemiaAggressive Non-Hodgkin LymphomaRefractory Plasma Cell MyelomaRecurrent Chronic Lymphocytic LeukemiaRefractory Hodgkin LymphomaRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Indolent Adult Non-Hodgkin Lymphoma
- Interventions
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2020-01-31
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 41
- Registration Number
- NCT00789776
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Blood Samples to Evaluate Biomarkers of Donor Chimerism
- Conditions
- First Posted Date
- 2008-10-02
- Last Posted Date
- 2012-02-15
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 80
- Registration Number
- NCT00764829
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Conditions
- Recurrent Plasma Cell MyelomaRefractory Chronic Myelogenous LeukemiaRefractory Follicular LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Mantle Cell LymphomaRecurrent Marginal Zone LymphomaRecurrent T-Cell Non-Hodgkin LymphomaRecurrent Lymphoplasmacytic LymphomaMyelodysplastic SyndromeMyeloproliferative Neoplasm
- Interventions
- First Posted Date
- 2008-07-28
- Last Posted Date
- 2019-12-27
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 73
- Registration Number
- NCT00723099
- Locations
- 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States
🇺🇸Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸Colorado Blood Cancer Institute, Denver, Colorado, United States
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease
- Conditions
- Interventions
- First Posted Date
- 2008-07-22
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 13
- Registration Number
- NCT00719849
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Conditions
- Acute Biphenotypic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaLymphoplasmacytic LymphomaMantle Cell LymphomaMyelodysplastic SyndromeNon-Hodgkin LymphomaAcute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2008-07-22
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 135
- Registration Number
- NCT00719888
- Locations
- 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States
🇺🇸VA Puget Sound Health Care System, Seattle, Washington, United States
🇺🇸Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
- Conditions
- Interventions
- Biological: Anti-Thymocyte GlobulinProcedure: Autologous Hematopoietic Stem Cell TransplantationDrug: CarmustineDrug: CytarabineDrug: EtoposideOther: Laboratory Biomarker AnalysisDrug: MelphalanProcedure: Peripheral Blood Stem Cell TransplantationDrug: PrednisoneProcedure: Syngeneic Bone Marrow Transplantation
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 53
- Registration Number
- NCT00716066
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸Swedish Medical Center-First Hill, Seattle, Washington, United States
🇺🇸Colorado Blood Cancer Institute, Denver, Colorado, United States
Move and Moderate in Balance
- Conditions
- First Posted Date
- 2008-07-15
- Last Posted Date
- 2011-12-07
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 31
- Registration Number
- NCT00715130
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Carotene and Retinol Efficacy Trial
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2012-09-26
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 18314
- Registration Number
- NCT00712647